secwatch.observer — SEC 8-K summary
======================================

Issuer:     CorMedix Inc. (CRMD)
CIK:        0001410098
Form:       8-K
Filed at:   2023-04-17T23:59:59+00:00
Accession:  0001213900-23-030043
Event type: leadership
Sentiment:  positive
Materiality: 0.50
Item codes: 5.02, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

CorMedix appoints Robert Stewart to Board of Directors
------------------------------------------------------

- Robert Stewart appointed to Board effective April 13, 2023; Board now has 8 directors, 7 independent.
- Stewart is CEO of Theramex; former CEO of Amneal Pharma and COO of Allergan.
- Received initial option for 25,000 shares (1/3 vesting at grant, then annually); additional prorated option for 14,200 shares.
- Stewart's experience expected to aid CorMedix's transition from development to commercial phase, per CEO.
- Press release highlights commercial potential for lead product DefenCath.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1410098/000121390023030043/0001213900-23-030043-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1410098/000121390023030043/ea177005-8k_cormedix.htm
  HTML page:      https://secwatch.observer/filing/0001213900-23-030043

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer